T2 Biosystems up on study to add new pathogen to detection panel

T2 Biosystems

20/10/2022 18:03

** Shares of U.S.-based in-vitro diagnostics co T2
Biosystems Inc  TTOO.O  rise 2.9% to $1.8
    ** Co says it has initiated studies to expand the number of
pathogens detected on its U.S. FDA-cleared sepsis detection
panel to include the detection of one more pathogen named
Acinetobacter baumannii  urn:newsml:reuters.com:*:nGNXb89MDh
    ** A.baumannii leads to bloodstream infections especially in
critically ill patients in healthcare settings and pose risk to
those who are on ventilators 
    ** Sepsis is a life-threatening condition caused by the
body's response to an infection
    ** Including session's gain, stock down 93.02% YTD
 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))